US Patent 7329661 N-phenyl-3-pyrimidine-amine derivatives
Patent 7329661 was granted and assigned to Novartis on February, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Giorgio Caravatti0
Hans Michael Buerger0
Juerg Zimmerman0
Margaret Amelia Cudd0
Paul William Manley0
Werner Breitenstein0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+92 characters)
Article
Patent abstract
The invention relates to N-phenyl-2-pyrimidine-amine derivatives of formula I
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07329661 N-phenyl-3-pyrimidine-amine derivatives US Patent 7329661 N-phenyl-3-pyrimidine-amine derivatives
Infobox
Patent Number
073296610
Patent Number
73296610
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073296610
Date of Patent
February 12, 2008
0Patent Application Number
118283670
Date Filed
July 26, 2007
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07329661 N-phenyl-3-pyrimidine-amine derivatives
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07329661
Date of patent
February 12, 2008
Patent application number
11828367
Date Filed
July 26, 2007
Patent primary examiner
Find more entities like US Patent 7329661 N-phenyl-3-pyrimidine-amine derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.